Pacific Biosciences Of California, Inc. share price logo

Pacific Biosciences Of California, Inc. Share Price

NASDAQ: PACB

Small Cap

$1.32

-0.08

(-5.71%)

as on

Pacific Biosciences Of California, Inc. Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's High

    $1.32
    $1.40

    6.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.85
    $2.73
    downward going graph

    35.52%

    Downside

    106.82%

    Upside

    downward going graph

Pacific Biosciences Of California, Inc. share price movements today

Previous Close
$1.40
Open
$1.39
Volume
5.3M
Day's Low - High
$1.32 - $1.40
52 Week Low - High
$0.85 - $2.73

Pacific Biosciences Of California, Inc. Historical Returns

1 Month Return
-13.04 %
3 Month Return
-23.91 %
1 Year Return
+ 11.11 %
3 Year Return
-83.25 %
5 Year Return
-95.81 %

Pacific Biosciences Of California, Inc. Stock Fundamentals & Key Indicators

Check Pacific Biosciences Of California, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$401.7M

EPS (TTM)

-0.5007

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.93

Industry PE ratio

-4.340170068027211

PEG Ratio

-0.17

EBITDA

-169.2M

Revenue (TTM)

160.0M

Profit Margin

0.00%

Return On Equity TTM

-213.45%

Pacific Biosciences Of California, Inc. Stock Valuation

Track how Pacific Biosciences Of California, Inc. P/E has moved over time to understand its valuation trends.

Pacific Biosciences Of California, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-94.60x)

March 31, 2021

Industry (-4.34x)

March 20, 2026

Today (-0.93x)

March 20, 2026

Highest (-1.16x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.93x

Pacific Biosciences Of California, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pacific Biosciences Of California, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Pacific Biosciences Of California, Inc. image
Pacific Biosciences Of California, Inc.
BUY$401.7M-95.81%-0.930.00%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$105.8B83.1%36.7414.44%
Stryker Corporation image
Stryker Corporation
BUY$132.3B47.72%41.1712.92%
Abbott Laboratories image
Abbott Laboratories
BUY$188.5B-10.86%29.1614.72%
Medtronic Plc image
Medtronic Plc
BUY$112.0B-25.51%24.3613.00%
See all

Stock Returns calculator for Pacific Biosciences Of California, Inc. Stock including INR - Dollar returns

The Pacific Biosciences Of California, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pacific Biosciences Of California, Inc. investment value today

Current value as on today

₹1,13,308

Returns

₹13,308

(+13.31%)

Returns from Pacific Biosciences Of California, Inc. Stock

₹4,762 (+4.76%)

Dollar Returns*

₹8,546 (+8.55%)

Analyst Recommendation on Pacific Biosciences Of California, Inc. Stock

Based on 20 analysts

BUY

55.00%

Buy

45.00%

Hold

0.00%

Sell

Based on 20 analysts, 55% of analysts recommend a 'BUY' rating for Pacific Biosciences Of California, Inc.. Average target price of $2.43

Pacific Biosciences Of California, Inc. Share Price Target

Get share price movements and forecasts by analysts on Pacific Biosciences Of California, Inc..

What analysts predicted

45.68%UPSIDE

Target Price

$2.43

Current Price

$1.32

Analyzed by

20 Analysts

Target

$2.43

Pacific Biosciences Of California, Inc. target price $2.43, a slight upside of 45.68% compared to current price of $1.32. According to 20 analysts rating.

Pacific Biosciences Of California, Inc. Stock’s Investor Sentiment and Interest

Investment in Pacific Biosciences Of California, Inc. Shares on INDmoney has grown by 102.43% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:102.43% versus previous 30 day period

Search interest for Pacific Biosciences Of California, Inc. Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:16% versus previous 30 day period

Pacific Biosciences Of California, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
55
58
38
36
39
39
37
39
38
44
Gross Profit
17
9
11
5
10
10
-1
14
15
16
Operating Income
-82
-87
-81
-175
-64
-153
-428
-44
-38
-41
EBITDA
-68
-61
-62
-155
-41
16
-51
-35
-34
-38
Interest Expense
3
3
3
3
3
2
1
1
1
1
Depreciation
0
11
12
14
16
10
372
4
4
4
Income Before Tax
-77
-82
-78
-173
-60
2
-426
-41
-37
-40
Income Tax Expense
-10
0
11
-
-60
0
0
0
0
0
Net Income
-66
-82
-78
-173
-60
2
-426
-41
-38
-40
Net Profit Margin
-120.07%
-140.55%
-201.44%
-481.27%
-151.94%
6.04%
-1146.81%
-105.44%
-98.85%
-90.43%

Pacific Biosciences Of California, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
90
93
78
90
78
130
128
200
154
160
Gross Profit
44
34
25
34
32
58
49
52
37
50
Operating Income
-71
-89
-100
-100
-104
-210
-307
-334
-474
-557
EBITDA
-67
-80
-92
-71
38
-250
-282
-271
-242
-34
Interest Expense
3
2
2
2
0
12
14
14
13
6
Depreciation
-
8
7
9
9
11
17
19
53
386
Income Before Tax
-74
-92
-102
-84
29
-274
-314
-318
-309
-546
Income Tax Expense
3
-5
0
-6
-6
-93
-17
-11
0
0
Net Income
-74
-92
-102
-84
29
-181
-314
-306
-309
-546
Net Profit Margin
-81.99%
-98.63%
-130.44%
-92.57%
37.27%
-138.85%
-244.92%
-152.97%
-201.18%
-341.47%

Pacific Biosciences Of California, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-82
-78
-173
-60
2
-426
-41
-38
-40
Operating Cash Flow
-57
-75
-54
-45
-30
-44
-29
-18
-19
Investing Cash Flow
-66
-34
76
23
58
45
25
18
26
Financing Cash Flow
-81
6
0
0
-50
1
-
1
-3
Change in Cash
-205
-103
22
-21
-22
3
-4
1
6

Pacific Biosciences Of California, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-92
-102
-84
29
-181
-314
-306
-309
-546
Operating Cash Flow
-67
-66
-78
19
-111
-263
-266
-206
-111
Investing Cash Flow
-1
-38
62
-219
-678
116
4
124
115
Financing Cash Flow
68
107
26
251
1,169
9
116
-42
3
Change in Cash
0
2
10
52
379
-137
-145
-124
7

Global Institutional Holdings in Pacific Biosciences Of California, Inc.

Funds
Holdings
Citadel Advisors Llc
1.05%
Susquehanna International Group, LLP
0.86%
Charles Schwab Investment Management Inc
0.82%
Northern Trust Corp
0.76%
UBS Group AG
0.5%
See all

Pacific Biosciences Of California, Inc. News & Key Events

  • img

    Today's Timeline - 05 March

    Thu, 09:27 PM

    -

    Pacific Biosciences reports Q4 2025 adjusted loss of 12 cents, exceeding estimates; revenues of $45 million also beat expectations.

Insights on Pacific Biosciences Of California, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PACB stock has moved up by 5.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 38.44M → 44.64M (in $), with an average increase of 13.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 1.7% return, outperforming this stock by 85.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 16.2% return, outperforming this stock by 5.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -38.0M → -40.37M (in $), with an average decrease of 6.2% per quarter

About Pacific Biosciences Of California, Inc.

pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
OrganisationPacific Biosciences Of California, Inc.
Headquarters1305 O?Brien Drive, Menlo Park, CA, United States, 94025
IndustryHealth Technology
CEOMr. Christian O. Henry M.B.A.
E-voting on sharesClick here to vote

Key Management of Pacific Biosciences Of California, Inc.

Name

Title

Mr. James R. Gibson II

Chief Financial Officer

Dr. Brett Atkins J.D., Ph.D.

General Counsel & Corporate Secretary

Mr. David Ruggiero

Global Head of Sales & Service

Ms. Natalie Welch

Chief People Officer

Mr. Christian O. Henry M.B.A.

President, CEO & Director

Mr. Mark Van Oene Ph.D.

Chief Operating Officer

Dr. Stephen Turner Ph.D.

Co-Founder

FAQs

What is Pacific Biosciences Of California, Inc. share price today?

Pacific Biosciences Of California, Inc. share price today is $1.32 as on at the close of the market. Pacific Biosciences Of California, Inc. share today touched a day high of $1.4 and a low of $1.32.

What is the 52 week high and 52 week low for Pacific Biosciences Of California, Inc. share?

Pacific Biosciences Of California, Inc. share touched a 52 week high of $2.73 on and a 52 week low of $0.85 on . Pacific Biosciences Of California, Inc. stock price today i.e. is closed at $1.32,which is 51.65% down from its 52 week high and 55.09% up from its 52 week low.

What is Pacific Biosciences Of California, Inc.'s market capitalisation today?

Pacific Biosciences Of California, Inc. market capitalisation is $0.00T as on .

How to invest in Pacific Biosciences Of California, Inc. Stock (PACB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pacific Biosciences Of California, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pacific Biosciences Of California, Inc. Shares that will get you 1.1364 shares as per Pacific Biosciences Of California, Inc. share price of $1.32 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pacific Biosciences Of California, Inc. Stock (PACB) from India?

Indian investors can start investing in Pacific Biosciences Of California, Inc. (PACB) shares with as little as ₹93.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Pacific Biosciences Of California, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Pacific Biosciences Of California, Inc. share’s latest price of $1.32 as on March 21, 2026 at 1:29 am IST, you will get 7.5758 shares of Pacific Biosciences Of California, Inc.. Learn more about fractional shares .

What are the returns that Pacific Biosciences Of California, Inc. has given to Indian investors in the last 5 years?

Pacific Biosciences Of California, Inc. stock has given -95.81% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?